In a related press release, lead author Gerald A. Beathard, MD, PhD, of the University of Texas Medical Branch, said, “The dramatic difference in durability between the endovascular fistulas and the ...

SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of ...

Please provide your email address to receive an email when new articles are posted on . Arteriovenous access use within 1 year after hemodialysis initiation increased in all racial/ethnic groups.

Novel Cell-Based Therapy Addresses Serious Unmet Medical Need, Aims to Reduce Need for Repeat Surgical Procedures and Improve Patient Outcomes CAMBRIDGE, Mass., Feb. 8, 2011 /PRNewswire/ -- Pervasis ...

The increased risk for venous thromboembolism with an arteriovenous graft is one factor for clinicians and patients to consider in the choice of vascular access for hemodialysis. Among permanent ...

Researchers found that eGFR decline decelerated significantly in patients with AVF/AVG, from -5.6 to -4.1 mL/min/1.73m2 per year. For patients with advanced chronic kidney disease (CKD), timely ...

Autologous arteriovenous access is the key to long-term success with hemodialysis and is strongly supported by the National Kidney Foundation's Dialysis Outcomes Quality Initiative guidelines. Basilic ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market Report for AV Fistula Needles 2017 - MedCore" report to their offering. An AV fistula needle enables access ...

Central venous catheters are currently the primary method of vascular haemodialysis access used by paediatric nephrologists in the USA. However, new data from Ma and colleagues suggest that in ...

Humacyte stock has dropped 46% since July, mainly due to FDA review delays and mixed Phase 3 trial results for their ATEVs in hemodialysis. Despite FDA approval of Symvess for vascular trauma, its ...